Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excretion Balance and PK of GSK2269557 in Healthy Males
NCT03315559Phase 1Completed
- Sponsor
- GSK
- Start
- Nov 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nemiralisib in chronic obstructive pulmonary disease (COPD) and asthma, sponsored by GSK. Primary endpoints: Area Under Concentration-time Curve From Time 0 to Infinite Time, Area Under Concentration-time Curve From Time 0 to Last Time of Quantifiable Concentration and 4 more. Started Nov 2017; status: completed.
02
Drugs
nemiralisib
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT03315559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315559.